Safety and Efficacy Study of an A1-Adenosine Receptor Agonist to Slow Heart Rate in Atrial Fibrillation
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the safety of DTI-0009 in patients with atrial
fibrillation and to find the dose of DTI-0009 that lowers heart rates in patients with atrial
fibrillation with rapid ventricular response.